Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep 23;20(19):4719.
doi: 10.3390/ijms20194719.

Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression

Affiliations
Review

Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression

Chloé Laplagne et al. Int J Mol Sci. .

Abstract

The tumor bulk is composed of a highly heterogeneous population of cancer cells, as well as a large variety of resident and infiltrating host cells, extracellular matrix proteins, and secreted proteins, collectively known as the tumor microenvironment (TME). The TME is essential for driving tumor development by promoting cancer cell survival, migration, metastasis, chemoresistance, and the ability to evade the immune system responses. Therapeutically targeting tumor-associated macrophages (TAMs), cancer-associated fibroblasts (CAFs), regulatory T-cells (T-regs), and mesenchymal stromal/stem cells (MSCs) is likely to have an impact in cancer treatment. In this review, we focus on describing the normal physiological functions of each of these cell types and their behavior in the cancer setting. Relying on the specific surface markers and secreted molecules in this context, we review the potential targeting of these cells inducing their depletion, reprogramming, or differentiation, or inhibiting their pro-tumor functions or recruitment. Different approaches were developed for this targeting, namely, immunotherapies, vaccines, small interfering RNA, or small molecules.

Keywords: CAFs; MSCs; T-regs; TAMs; resistance; tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.

Figures

Figure 1
Figure 1
Representation of the tumor microenvironment (TME) with tumor-associated macrophages (TAMs), mesenchymal stromal/stem cells (MSCs), regulatory T-cells (T-regs), and cancer-associated fibroblasts (CAFs) infiltrating the tumor.
Figure 2
Figure 2
Targeting strategies to reprogram, eliminate, and inhibit TAM recruitment. Antibodies or molecules available to target surface, intracellular or soluble molecules involved in the phenotype, functions, and recruitment of TAMs in the TME (as outlined in the text).
Figure 3
Figure 3
Targeting strategies to eliminate or modulate T-reg functions. Available antibodies, small molecules, or vaccines specific for different cell surface or intracellular targets (as outlined in the text).

References

    1. Roma-Rodrigues C., Mendes R., Baptista P.V., Fernandes A.R. Targeting Tumor Microenvironment for Cancer Therapy. Int. J. Mol. Sci. 2019;20:840. doi: 10.3390/ijms20040840. - DOI - PMC - PubMed
    1. Hanahan D., Coussens L.M. Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment. Cancer Cell. 2012;21:309–322. doi: 10.1016/j.ccr.2012.02.022. - DOI - PubMed
    1. Wang M., Zhao J., Zhang L., Wei F., Lian Y., Wu Y., Gong Z., Zhang S., Zhou J., Cao K., et al. Role of tumor microenvironment in tumorigenesis. J. Cancer. 2017;8:761–773. doi: 10.7150/jca.17648. - DOI - PMC - PubMed
    1. Kim K., Marquez-Palencia M., Malladi S. Metastatic Latency, a Veiled Threat. Front. Immunol. 2019;10:1836. doi: 10.3389/fimmu.2019.01836. - DOI - PMC - PubMed
    1. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer. 2009;9:239–252. doi: 10.1038/nrc2618. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources